Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Annals of Clinical and Translational Neurology|April 26, 2019
Higher risk of dementia in primary Sjogren's syndromeTsung-Yun Hou, Hui-Ching Hsu, Tzu-Min Lin, et al.Arthritis Research & Therapy|February 22, 2022
TLC599 in patients with osteoarthritis of the knee: a phase IIa, randomized, placebo-controlled, dose-finding studyDavid J Hunter, Chi-Ching Chang, James Cheng-Chung Wei, et al.Annals of Clinical and Translational Neurology|June 2, 2020
Risk of incident autoimmune diseases in patients with thymectomyTzu-Min Lin, Yu-Sheng Chang, Tsung-Yun Hou, et al.Clinical and Experimental Dermatology|July 28, 2025
Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and ulcerative colitis: A cohort studyTzu-Min Lin, Yu-Sheng Chang, Yu-Chuan Shen, et al.Frontiers in Immunology|October 24, 2022
Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort studyShu-Ming Chou, Hsing-Jung Yeh, Tzu-Min Lin, et al.Scientific Reports|January 16, 2021
Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jawPei-I Kuo, Tzu-Min Lin, Yu-Sheng Chang, et al.Arthritis Research & Therapy|April 16, 2025
Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort studyWei-Sheng Chen, Hui-Ching Hsu, Tzu-Min Lin, et al.Frontiers in Immunology|October 18, 2021
Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort StudySheng-Hong Lin, Yu-Sheng Chang, Tzu-Min Lin, et al.Human Genetics|August 10, 2016
Identification of susceptibility gene associated with female primary Sjögren's syndrome in Han Chinese by genome-wide association studyI-Wen Song, Hsiang-Cheng Chen, Yuh-Feng Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus InfectionYu-Chuan Shen, Hui-Ching Hsu, Tzu-Min Lin, et al.Pageof 7